Procurement Summary
Country : Poland
Summary : "Successive Delivery of the Surveyed Medicinal Products with the Active Substance of Amodernon, Sotalol, Metoprolol, Bisoprolol and Support for Non -Commercial Clinical Examination in the Scope of Repacking, Labels ...
Deadline : 14 Apr 2025
Other Information
Notice Type : Tender
TOT Ref.No.: 117366513
Document Ref. No. : 226927-2025
Competition : ICB
Financier : Self Financed
Purchaser Ownership : Public
Tender Value : Refer Document
Purchaser's Detail
Name :Login to see tender_details
Address : Login to see tender_details
Email : Login to see tender_details
Login to see detailsTender Details
"Successive delivery of the surveyed medicinal products with the active substance amodernon, sotalol, metoprolol, bisoprolol and support for non -commercial clinical examination in the field of repacking, labels ...
" Successive delivery of studied medicinal products with active substance amylonon, sotalol, sotalol, Metoprolol, bisoprolol and service of non -commercial clinical examination in the field of repacking, labeling, exemption for clinical examination, delivery of medicinal products and utilization of the examined medicinal products for the purposes of clinical examination (...) "
The subject of the contract is the subject of the contractSuccessive delivery of the surveyed medicinal products with the active substance of amylone, sotalol, metoprolol, bisoprolol and service of non -commercial clinical examination in the field of repacking, labeling, exemption for clinical examination, delivery of medicinal products and disposal of the respondentsmedicinal products for the needs of a clinical examination entitled "Early ablation of atrial fibrillation in patients with hyperplasia.clinical research), in which the sponsor is the National Institute of Cardiology of Stefan Cardinal Wyszyński - National Research Institute.medicinal product with active substance amodelone in an amount of 83, 000 tablets after 200mg
part 2 - Successive delivery of the medicinal product with the active substance sotalol in the amount of 70, 000 tablets after80m...
Document Type: Contract Notice
Reference Number: ZP.008.2025
Contract Type: Services
Authority Type: BODY-PL
DOC TITLE: "Successive delivery of studied medicinal products with active substance amodularon, sotalol, metoprolol, bisoprolol and service clinical in terms ofrepacking, labeling, exemption for clinical examination, delivery of medicinal products and utilization of the examined medicinal products for the purposes of clinical examination (...) "
Dispatch Date: 2025-04-04-04
Publish date: 2025-04-08
Submission Date:2025-04-14
Documents
Tender Notice